OBJECTIVES: To evaluate the prevalence, impact, and risk factors for pain among a cohort of human immunodeficiency virus (HIV)-infected adults treated with combination antiretroviral therapy if indicated according to current guidelines. METHODS: This was a cross-sectional epidemiological observational study. All patients attending 1 HIV-outpatient center in the United Kingdom in a 10-month period were eligible. Patients completed a validated questionnaire enquiring about demographics, HIV factors, and symptoms of pain. RESULTS: Of 1050 eligible participants, 859 (82%) completed a questionnaire. The 1-month period prevalence of pain lasting >1 day was 62.8% among whom 63% reported current pain. The prevalence of pain at most anatomic sites was broadly similar to that observed in population studies using the same questionnaires except that we found considerably higher rates of foot/ankle pain. The median duration of pain was 3 years (range, 0 to 51 y) and the median pain score was 5.0 on an 11-point visual analogue score. Over 40% of people in pain had consulted their primary care physician and >20% were taking analgesics daily. Independent risk factors for current pain were older age (P=0.001), time since diagnosis of HIV infection (P=0.001), and receipt of a protease inhibitor-based regimen (P=0.04). DISCUSSION: Pain, and notably foot/ankle pain, is common among adults living with prevalent HIV and is associated with substantial morbidity and health care utilization.
OBJECTIVES: To evaluate the prevalence, impact, and risk factors for pain among a cohort of human immunodeficiency virus (HIV)-infected adults treated with combination antiretroviral therapy if indicated according to current guidelines. METHODS: This was a cross-sectional epidemiological observational study. All patients attending 1 HIV-outpatient center in the United Kingdom in a 10-month period were eligible. Patients completed a validated questionnaire enquiring about demographics, HIV factors, and symptoms of pain. RESULTS: Of 1050 eligible participants, 859 (82%) completed a questionnaire. The 1-month period prevalence of pain lasting >1 day was 62.8% among whom 63% reported current pain. The prevalence of pain at most anatomic sites was broadly similar to that observed in population studies using the same questionnaires except that we found considerably higher rates of foot/ankle pain. The median duration of pain was 3 years (range, 0 to 51 y) and the median pain score was 5.0 on an 11-point visual analogue score. Over 40% of people in pain had consulted their primary care physician and >20% were taking analgesics daily. Independent risk factors for current pain were older age (P=0.001), time since diagnosis of HIV infection (P=0.001), and receipt of a protease inhibitor-based regimen (P=0.04). DISCUSSION: Pain, and notably foot/ankle pain, is common among adults living with prevalent HIV and is associated with substantial morbidity and health care utilization.
Authors: Michael J Silverberg; Lisa P Jacobson; Audrey L French; Mallory D Witt; Stephen J Gange Journal: J Pain Symptom Manage Date: 2009-03-28 Impact factor: 3.612
Authors: David J Kim; Andrew O Westfall; Eric Chamot; Amanda L Willig; Michael J Mugavero; Christine Ritchie; Greer A Burkholder; Heidi M Crane; James L Raper; Michael S Saag; James H Willig Journal: J Acquir Immune Defic Syndr Date: 2012-12-15 Impact factor: 3.731
Authors: C Del Borgo; I Izzi; F Chiarotti; A Del Forno; A M Moscati; E Cornacchione; M Fantoni Journal: AIDS Patient Care STDS Date: 2001-02 Impact factor: 5.078
Authors: Jessica S Merlin; Andrew O Westfall; James L Raper; Anne Zinski; Wynne E Norton; James H Willig; Robert Gross; Christine S Ritchie; Michael S Saag; Michael J Mugavero Journal: J Acquir Immune Defic Syndr Date: 2012-10-01 Impact factor: 3.731
Authors: Samuel F Freedman; Carrie Johnston; John J Faragon; Eugenia L Siegler; Tessa Del Carmen Journal: Eur Geriatr Med Date: 2018-12-06 Impact factor: 1.710
Authors: Celia C Y Wong; Daniel J Paulus; Chad Lemaire; Amy Leonard; Carla Sharp; Clayton Neighbors; Charles P Brandt; Qian Lu; Michael J Zvolensky Journal: J HIV AIDS Soc Serv Date: 2017-11-30
Authors: Andrea H Weinberger; Elizabeth K Seng; Joseph W Ditre; Melody Willoughby; Jonathan Shuter Journal: Nicotine Tob Res Date: 2019-03-30 Impact factor: 4.244
Authors: Joan N Chukwurah; Joachim Voss; Susan R Mazanec; Ann Avery; Allison Webel Journal: J Assoc Nurses AIDS Care Date: 2020 May-Jun Impact factor: 1.354
Authors: Burel R Goodin; Michael A Owens; Lindsey R Yessick; Rachael L Rainey; Jennifer I Okunbor; Dyan M White; Kaneisha A Mushatt; Olivia A Harmon; Sonya L Heath; Jessica S Merlin Journal: Pain Med Date: 2017-12-01 Impact factor: 3.750